Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).:
SEC Accession No. 0001015820-17-000013
Filing Date
2017-03-06
Accepted
2017-03-03 19:42:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 IRANNOTICE a2016irannotice.htm IRANNOTICE 6418
2 qgennewheaderlogoa13.jpg GRAPHIC 11495
3 qiagenfootera10.jpg GRAPHIC 7766
  Complete submission text file 0001015820-17-000013.txt   32229
Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: IRANNOTICE | Act: 34 | File No.: 000-28564 | Film No.: 17666187
SIC: 2836 Biological Products, (No Diagnostic Substances)